Raffaella DeRosa1, Michael B Lustik2, Danielle A Stackhouse3, Leah P McMann3. 1. Division of Urology, Department of Surgery, Tripler Army Medical Center, Honolulu, HI. Electronic address: Raffaella.Derosa.mil@mail.mil. 2. Department of Clinical Investigation, Tripler Army Medical Center, Honolulu, HI. 3. Division of Urology, Department of Surgery, Tripler Army Medical Center, Honolulu, HI.
Abstract
OBJECTIVE: To evaluate the impact of the 2012 American Urological Association vasectomy guidelines on postvasectomy clinical outcomes in a highly mobile military cohort and compare these outcomes with those of civilian counterparts. METHODS: The records of service members who underwent vasectomy between January 2008 and December 2013 and provided at least 1 postvasectomy semen analysis (PVSA) were analyzed in the context of the 2012 guidelines. Time to occlusive success, repeat PVSAs and vasectomies, and health care cost savings were compared between our prior definition of vasectomy success, which required azoospermia, and the 2012 criteria, which included rare nonmotile sperm. RESULTS: Of the 1623 men who underwent vasectomy, 738 men (45%) failed to submit a PVSA, leaving 895 men (55%) who provided at least 1 PVSA. A total of 1084 PVSAs were obtained in these men, who had a mean age of 37 ± 6 years. Defining success as azoospermia on first PVSA resulted in a sterility rate of 69%. After application of the 2012 guidelines, 845 patients (94%) achieved sterility by the first PVSA and more patients achieved sterility 60 days from vasectomy (96% vs 72%; P <.001). Inclusion of rare nonmotile sperm in our definition of success would have allowed 228 men to forego a second PVSA and prevented 2 (0.002%) unnecessary vasectomies, a savings of $6297. CONCLUSION: PVSA compliance in our military cohort was similar to that of civilian counterparts. The American Urological Association vasectomy guidelines have the potential to decrease the number of repeat vasectomies and laboratory tests, improve the documented success rate, and increase follow-up compliance when applied to a military population. Published by Elsevier Inc.
OBJECTIVE: To evaluate the impact of the 2012 American Urological Association vasectomy guidelines on postvasectomy clinical outcomes in a highly mobile military cohort and compare these outcomes with those of civilian counterparts. METHODS: The records of service members who underwent vasectomy between January 2008 and December 2013 and provided at least 1 postvasectomy semen analysis (PVSA) were analyzed in the context of the 2012 guidelines. Time to occlusive success, repeat PVSAs and vasectomies, and health care cost savings were compared between our prior definition of vasectomy success, which required azoospermia, and the 2012 criteria, which included rare nonmotile sperm. RESULTS: Of the 1623 men who underwent vasectomy, 738 men (45%) failed to submit a PVSA, leaving 895 men (55%) who provided at least 1 PVSA. A total of 1084 PVSAs were obtained in these men, who had a mean age of 37 ± 6 years. Defining success as azoospermia on first PVSA resulted in a sterility rate of 69%. After application of the 2012 guidelines, 845 patients (94%) achieved sterility by the first PVSA and more patients achieved sterility 60 days from vasectomy (96% vs 72%; P <.001). Inclusion of rare nonmotile sperm in our definition of success would have allowed 228 men to forego a second PVSA and prevented 2 (0.002%) unnecessary vasectomies, a savings of $6297. CONCLUSION: PVSA compliance in our military cohort was similar to that of civilian counterparts. The American Urological Association vasectomy guidelines have the potential to decrease the number of repeat vasectomies and laboratory tests, improve the documented success rate, and increase follow-up compliance when applied to a military population. Published by Elsevier Inc.
Authors: Ashok Agarwal; Sajal Gupta; Rakesh K Sharma; Renata Finelli; Shinnosuke Kuroda; Sarah C Vij; Florence Boitrelle; Parviz Kavoussi; Amarnath Rambhatla; Ramadan Saleh; Eric Chung; Taymour Mostafa; Armand Zini; Edmund Ko; Neel Parekh; Marlon Martinez; Mohamed Arafa; Nicholas Tadros; Jean de la Rosette; Tan V Le; Osvaldo Rajmil; Hussein Kandil; Gideon Blecher; Giovanni Liguori; Ettore Caroppo; Christopher C K Ho; Andrew Altman; Petar Bajic; David Goldfarb; Bradley Gill; Daniel Suslik Zylbersztejn; Juan Manuel Corral Molina; Marcello M Gava; Joao Paulo Greco Cardoso; Raghavender Kosgi; Gökhan Çeker; Birute Zilaitiene; Edoardo Pescatori; Edson Borges; Gede Wirya Kusuma Duarsa; Germar-Michael Pinggera; Gian Maria Busetto; Giancarlo Balercia; Giorgio Franco; Gökhan Çalik; Hassan N Sallam; Hyun Jun Park; Jonathan Ramsay; Juan Alvarez; Kareim Khalafalla; Kasonde Bowa; Lukman Hakim; Mara Simopoulou; Marcelo Gabriel Rodriguez; Marjan Sabbaghian; Haitham Elbardisi; Massimiliano Timpano; Mesut Altan; Mohamed Elkhouly; Mohamed S Al-Marhoon; Mohammad Ali Sadighi Gilani; Mohammad Ayodhia Soebadi; Mohammad Hossein Nasr-Esfahani; Nicolas Garrido; Paraskevi Vogiatzi; Ponco Birowo; Premal Patel; Qaisar Javed; Rafael F Ambar; Ricky Adriansjah; Sami AlSaid; Sava Micic; Sheena E Lewis; Shingai Mutambirwa; Shinichiro Fukuhara; Sijo Parekattil; Sun Tae Ahn; Sunil Jindal; Teppei Takeshima; Ana Puigvert; Toshiyasu Amano; Trenton Barrett; Tuncay Toprak; Vineet Malhotra; Widi Atmoko; Yasushi Yumura; Yoshiharu Morimoto; Thiago Fernandes Negris Lima; Yannic Kunz; Yuki Kato; Yukihiro Umemoto; Giovanni M Colpi; Damayanthi Durairajanayagam; Rupin Shah Journal: World J Mens Health Date: 2022-01-02 Impact factor: 6.494
Authors: Darshan P Patel; Letitia Williams; Lee Warner; Mary E O'Neil; Kenneth Aston; Douglas T Carrell; Violanda Grigorescu; Denise J Jamieson; John R Gannon; Michael L Eisenberg; Thomas J Walsh; James M Hotaling Journal: Transl Androl Urol Date: 2018-07